Gabriel N. Hortobágyi

Researcher Next ID · RN-001384

Researcher · Biochemistry, Genetics and Molecular Biology

Houston, United States

Not currently recruitingFunding unknown

Research interests

Biochemistry, Genetics and Molecular Biology

Medicine

Breast Cancer Treatment Studies

Cancer Treatment and Pharmacology

HER2/EGFR in Cancer Research

Advanced Breast Cancer Therapies

Breast Lesions and Carcinomas

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1609709
Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmoa1109653
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
Journal of Clinical Oncology · 2008 · https://doi.org/10.1200/jco.2007.14.4147
Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy
Clinical Cancer Research · 2005 · https://doi.org/10.1158/1078-0432.ccr-04-2421
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
Cancer Cell · 2004 · https://doi.org/10.1016/j.ccr.2004.06.022

No projects listed.